Table 3 Baseline laboratory characteristics of the two groups (mean ± SD)
From: Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon
CSFP group (n = 64) | Control group (n = 50) | P value | |
|---|---|---|---|
WBC(109/L) | 6.8 ± 1.6 | 6.2 ± 1.5 | 0.56 |
RDW(%) | 13.2 ± 0.8 | 12.7 ± 0.6 | 0.37 |
MPV(fl) | 10.5 ± 1.1 | 10.3 ± 0.8 | 0.04 |
PDW(%) | 11.2 ± 1.1 | 10.7 ± 0.8 | 0.45 |
HDL-C(mmol/l)(mmol/l) | 1.0 ± 0.4 | 1.1 ± 0.6 | 0.46 |
LDL-C(mmol/l) | 2.5 ± 0.8 | 2.8 ± 0.7 | 0.20 |
TG(mmol/l) | 1.4 ± 1.0 | 1.3 ± 0.9 | 0.67 |
TC(mmol/l) | 4.3 ± 0.7 | 4.5 ± 0.9 | 0.22 |
FG (mmol/L) | 5.4 ± 0.8 | 5.7 ± 0.7 | 0.18 |
Creatinine(mg/dl) | 57.7 ± 11.2 | 55.5 ± 13.9 | 0.29 |
Cys-C(mg/l) | 1.0 ± 0.3 | 0.9 ± 0.1 | 0.31 |
UA(umol/l) | 309.5 ± 72.5 | 301.2 ± 62.5 | 0.64 |
GGT(U/l) | 33.0 ± 28.5 | 35.0 ± 32.2 | 0.82 |
ALP(U/l) | 70.5 ± 17.1 | 61.9 ± 16.1 | 0.007 |